BMS-790052 (Daclatasvir)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | BMS-790052 is an NS5A inhibitor under investigation for the treatment of hepatitis C virus (HCV) infection. |
---|
Catalog Num | A10159 |
---|---|
Formula | C40H50N8O6 |
Molecular Weight | 738.9 |
CAS Number | 1214735-16-6, 1009119-64-5 |
SMILES | CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 129 mg/mL (174.59 mM) | |
Water | Insoluble | ||
Ethanol | 129 mg/mL (174.59 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 13.53 mL | 67.67 mL | 135.34 mL |
0.5 mM | 2.71 mL | 13.53 mL | 27.07 mL |
1 mM | 1.35 mL | 6.77 mL | 13.53 mL |
5 mM | 0.27 mL | 1.35 mL | 2.71 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2